FDA Approves Chikungunya Vaccine

The U.S. Food and Drug Administration (FDA) has approved VIMKUNYA (chikungunya vaccine, recombinant) for injection, the first virus-like particle (VLP) single-dose chikungunya vaccine in the U.S. for persons 12 years of age and older. 

FDA Approves New Medication for Acute Pain

Image of a human body, with acute pain in the neck illustrated with a radiating yellow/red burst

The U.S. Food and Drug Administration has approved Vertex Pharmaceutical’s Journavx (suzetrigine), a new type of prescription pain medication for adults to treat moderate to severe acute pain.